Ardelyx (ARDX) Cash & Current Investments (2013 - 2026)

Ardelyx (ARDX) reported Cash & Current Investments of $238.1 million for Q1 2026, up 11.27% on a YoY basis from $214.0 million in Q1 2025, and down 10.06% quarter-over-quarter from $264.7 million in Q4 2025.

Ardelyx (ARDX) Cash & Current Investments (2013 - 2026) Analysis & Trends

Ardelyx has reported Cash & Current Investments for 14 years, with the latest figure at $238.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 11.27% year-over-year to $238.1 million; the trailing twelve-month figure through Mar 2026 stood at $238.1 million (up 11.27% YoY), and the FY2025 full-year result was $264.7 million, up 5.83% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $238.1 million, down from $264.7 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $264.7 million in Q4 2025, with the low at $81.0 million in Q2 2022.
  • Historically, Cash & Current Investments has averaged $177.6 million across 5 years, with a median of $186.0 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 52.85% — and 2023, when it soared 82.16%.
  • Ardelyx's Cash & Current Investments stood at $123.9 million in 2022, then surged by 48.74% to $184.3 million in 2023, then jumped by 35.7% to $250.1 million in 2024, then climbed by 5.83% to $264.7 million in 2025, then decreased by 10.06% to $238.1 million in 2026.
  • The last three Cash & Current Investments figures came in at $238.1 million (Q1 2026), $264.7 million (Q4 2025), and $242.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 238.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 238.07 Mn
Dec 31, 2025 264.69 Mn
Sep 30, 2025 242.71 Mn
Jun 30, 2025 238.45 Mn
Mar 31, 2025 213.95 Mn
Dec 31, 2024 250.10 Mn
Sep 30, 2024 190.40 Mn
Jun 30, 2024 185.96 Mn
Mar 31, 2024 202.58 Mn
Dec 31, 2023 184.30 Mn
Sep 30, 2023 165.08 Mn
Jun 30, 2023 127.58 Mn
Mar 31, 2023 130.37 Mn
Dec 31, 2022 123.91 Mn
Sep 30, 2022 90.62 Mn
Jun 30, 2022 81.01 Mn
Mar 31, 2022 89.70 Mn
Dec 31, 2021 116.69 Mn
Sep 30, 2021 141.65 Mn
Jun 30, 2021 171.81 Mn